ECCA, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 567
EU - Europa 99
AS - Asia 67
OC - Oceania 4
AF - Africa 1
SA - Sud America 1
Totale 739
Nazione #
US - Stati Uniti d'America 566
IT - Italia 45
CN - Cina 27
SG - Singapore 22
UA - Ucraina 14
IE - Irlanda 12
FR - Francia 10
DE - Germania 9
TR - Turchia 9
SE - Svezia 5
NZ - Nuova Zelanda 4
VN - Vietnam 4
JP - Giappone 2
TW - Taiwan 2
AT - Austria 1
CA - Canada 1
CL - Cile 1
ES - Italia 1
HK - Hong Kong 1
NO - Norvegia 1
RU - Federazione Russa 1
TG - Togo 1
Totale 739
Città #
Fairfield 103
Houston 50
Seattle 45
Cambridge 43
Woodbridge 43
Ashburn 42
Wilmington 41
Ann Arbor 26
Chandler 24
Dearborn 24
Singapore 18
Udine 13
Boardman 12
Dublin 12
Izmir 9
Princeton 9
Jacksonville 8
Beijing 6
Des Moines 5
Auckland 4
Cagliari 4
Cormons 4
Dong Ket 4
Ogden 4
Redmond 4
Rome 4
Shenzhen 4
Chengdu 3
Nanjing 3
San Diego 3
Azzano Decimo 2
Phoenix 2
Redwood City 2
Wuhan 2
Andover 1
Deiva Marina 1
Fuzhou 1
Genova 1
Guangzhou 1
Hangzhou 1
Jinan 1
Lomé 1
Munich 1
Novokuznetsk 1
Ottawa 1
Padova 1
Piemonte 1
Polcenigo 1
Santiago 1
Shenyang 1
Taipei 1
Torino 1
Vienna 1
Woodridge 1
Totale 602
Nome #
Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC) 117
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects 112
PHARMACOGENETICS OF FLUOROPYRIMIDINES: FROM THE IMPLEMENTATION OF GUIDELINES TO IDENTIFICATION OF NOVEL GERMLINE VARIANTS RELATED TO TOXICITY 95
Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity 93
Immunogenetics of prostate cancer: A still unexplored field of study 79
The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with fluoropyrimidines 73
Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation 67
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients 67
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 48
Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk 29
Totale 780
Categoria #
all - tutte 2.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020175 0 0 0 0 23 45 32 26 27 11 2 9
2020/2021157 2 33 1 20 10 13 32 13 11 7 7 8
2021/202279 7 6 3 2 4 4 3 1 3 19 17 10
2022/202388 9 0 1 20 6 31 0 2 8 0 3 8
2023/202460 6 0 2 0 20 5 5 4 7 1 0 10
2024/202550 10 15 3 13 9 0 0 0 0 0 0 0
Totale 780